| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 9793369
[patent_doc_number] => 20150005314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'PHARMACEUTICAL PREPARATION COMPRISING BREXPIRAZOLE AND SUBSTITUTED BETA-CYCLODEXTRIN'
[patent_app_type] => utility
[patent_app_number] => 14/369386
[patent_app_country] => US
[patent_app_date] => 2012-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3678
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369386
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/369386 | PHARMACEUTICAL PREPARATION COMPRISING BREXPIRAZOLE AND SUBSTITUTED BETA-CYCLODEXTRIN | Dec 27, 2012 | Abandoned |
Array
(
[id] => 8822187
[patent_doc_number] => 20130123232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/718056
[patent_app_country] => US
[patent_app_date] => 2012-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 129309
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13718056
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/718056 | Azetidinyl diamides as monoacylglycerol lipase inhibitors | Dec 17, 2012 | Issued |
Array
(
[id] => 8822188
[patent_doc_number] => 20130123233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/718257
[patent_app_country] => US
[patent_app_date] => 2012-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126148
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13718257
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/718257 | Azetidinyl diamides as monoacylglycerol lipase inhibitors | Dec 17, 2012 | Issued |
Array
(
[id] => 8940491
[patent_doc_number] => 20130190288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'BENZYL SULFONAMIDE DERIVATIVES AS RORC MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/717998
[patent_app_country] => US
[patent_app_date] => 2012-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24412
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13717998
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/717998 | Benzyl sulfonamide derivatives as RORc modulators | Dec 17, 2012 | Issued |
Array
(
[id] => 8780612
[patent_doc_number] => 20130102585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/716705
[patent_app_country] => US
[patent_app_date] => 2012-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 127906
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13716705
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/716705 | Azetidinyl diamides as monoacylglycerol lipase inhibitors | Dec 16, 2012 | Issued |
Array
(
[id] => 10975436
[patent_doc_number] => 20140378472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'AMORPHOUS VILAZODONE HYDROCHLORIDE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/363393
[patent_app_country] => US
[patent_app_date] => 2012-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 1322
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363393
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/363393 | AMORPHOUS VILAZODONE HYDROCHLORIDE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF | Dec 11, 2012 | Abandoned |
Array
(
[id] => 10857590
[patent_doc_number] => 08883789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors'
[patent_app_type] => utility
[patent_app_number] => 13/709312
[patent_app_country] => US
[patent_app_date] => 2012-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33856
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13709312
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/709312 | Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors | Dec 9, 2012 | Issued |
Array
(
[id] => 11230899
[patent_doc_number] => 09458120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Phenoxypropanol derivative and pharmaceutical composition including the same'
[patent_app_type] => utility
[patent_app_number] => 14/361844
[patent_app_country] => US
[patent_app_date] => 2012-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15779
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361844
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/361844 | Phenoxypropanol derivative and pharmaceutical composition including the same | Nov 29, 2012 | Issued |
Array
(
[id] => 8884860
[patent_doc_number] => 20130158044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/688108
[patent_app_country] => US
[patent_app_date] => 2012-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32647
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13688108
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/688108 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Nov 27, 2012 | Issued |
Array
(
[id] => 8842060
[patent_doc_number] => 20130137688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/684606
[patent_app_country] => US
[patent_app_date] => 2012-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15456
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13684606
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/684606 | N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors | Nov 25, 2012 | Issued |
Array
(
[id] => 9082176
[patent_doc_number] => 20130267706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'GUANIDINE-CONTAINING COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/681794
[patent_app_country] => US
[patent_app_date] => 2012-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26680
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13681794
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/681794 | Guanidine-containing compounds useful as muscarinic receptor antagonists | Nov 19, 2012 | Issued |
Array
(
[id] => 9657355
[patent_doc_number] => 20140228361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'AMINOQUINAZOLINE DERIVATIVES AND THEIR SALTS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/346741
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 57412
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346741
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346741 | Aminoquinazoline derivatives and their salts and methods of use | Nov 13, 2012 | Issued |
Array
(
[id] => 9786314
[patent_doc_number] => 20140303134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'PLATINUM COMPOUNDS THAT INHIBIT CONSTITUTIVE STAT3 SIGNALING AND INDUCE CELL CYCLE ARREST AND APOPTOSIS OF MALIGNANT CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/354400
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17935
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354400
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354400 | PLATINUM COMPOUNDS THAT INHIBIT CONSTITUTIVE STAT3 SIGNALING AND INDUCE CELL CYCLE ARREST AND APOPTOSIS OF MALIGNANT CELLS | Oct 25, 2012 | Abandoned |
Array
(
[id] => 10103810
[patent_doc_number] => 09139585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-22
[patent_title] => 'Inhibitors of the Renal Outer Medullary Potassium channel'
[patent_app_type] => utility
[patent_app_number] => 14/353804
[patent_app_country] => US
[patent_app_date] => 2012-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38957
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353804
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/353804 | Inhibitors of the Renal Outer Medullary Potassium channel | Oct 24, 2012 | Issued |
Array
(
[id] => 9951205
[patent_doc_number] => 08999991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Inhibitors of the renal outer medullary potassium channel'
[patent_app_type] => utility
[patent_app_number] => 14/353418
[patent_app_country] => US
[patent_app_date] => 2012-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19867
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353418
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/353418 | Inhibitors of the renal outer medullary potassium channel | Oct 21, 2012 | Issued |
Array
(
[id] => 9772562
[patent_doc_number] => 20140296225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'Inhibitors of the Renal Outer Medullary Potassium Channel'
[patent_app_type] => utility
[patent_app_number] => 14/353410
[patent_app_country] => US
[patent_app_date] => 2012-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37555
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353410
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/353410 | Inhibitors of the renal outer medullary potassium channel | Oct 21, 2012 | Issued |
Array
(
[id] => 9858475
[patent_doc_number] => 20150038493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'COMPOUNDS THAT TRAP ALPHA-OXOALDEHYDES AND ALPHA-BETA-UNSATURATED ALDEHYDES, META-COMPOUNDS CONTAINING SUCH COMPOUNDS, AND USE OF SAID COMPOUNDS IN TREATING ILLNESSES RELATED TO THE ACCUMULATION OF AGES AND ALES'
[patent_app_type] => utility
[patent_app_number] => 14/350126
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10932
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350126
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350126 | COMPOUNDS THAT TRAP ALPHA-OXOALDEHYDES AND ALPHA-BETA-UNSATURATED ALDEHYDES, META-COMPOUNDS CONTAINING SUCH COMPOUNDS, AND USE OF SAID COMPOUNDS IN TREATING ILLNESSES RELATED TO THE ACCUMULATION OF AGES AND ALES | Oct 4, 2012 | Abandoned |
Array
(
[id] => 9710849
[patent_doc_number] => 08835417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Crystalline hydrochloride salt of (1-(4-fluorophenyl)-1H-indol-5-yl)-(3-(4-(thiazole-2-carbonyl)piperazin-1-yl)azetidin-1-yl)methanone'
[patent_app_type] => utility
[patent_app_number] => 13/628331
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4649
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13628331
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/628331 | Crystalline hydrochloride salt of (1-(4-fluorophenyl)-1H-indol-5-yl)-(3-(4-(thiazole-2-carbonyl)piperazin-1-yl)azetidin-1-yl)methanone | Sep 26, 2012 | Issued |
Array
(
[id] => 8768051
[patent_doc_number] => 20130096088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'Inhibitors of Protein Tyrosine Kinase Activity'
[patent_app_type] => utility
[patent_app_number] => 13/629050
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34435
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13629050
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/629050 | Inhibitors of Protein Tyrosine Kinase Activity | Sep 26, 2012 | Abandoned |
Array
(
[id] => 8768098
[patent_doc_number] => 20130096135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'Selected Inhibitors of Protein Tyrosine Kinase Activity'
[patent_app_type] => utility
[patent_app_number] => 13/628975
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20602
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13628975
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/628975 | Selected Inhibitors of Protein Tyrosine Kinase Activity | Sep 26, 2012 | Abandoned |